Arquimea Ingeniera
VC Fund
Madrid, Spain
Arquimea Ingeniera is a VC fund in Madrid focused on Medical and Pharmaceutical. ARQUIMEA develops electronic, microelectronic, and electro-mechanic systems and components, including smart actuators and mechanisms, sensing systems, integrated circuits (IC) and robotic parts. ARQUIMEA’s products and technologies are suitable for those markets and sectors demanding innovation, quality, high performance and reliability, such asAerospace, Defence & Security, Industry, Automotive, Medical or Agroindustry.ARQUIMEA is committed to offer its clients products adapted to their needs and expert technical advice, with the goal of collaborating in the progress and development of the society in which we live.Production processes at ARQUIMEA are developed following the strictest and most exhaustive international quality regulations.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Arquimea Ingeniera invests in
Stages Arquimea Ingeniera invests in
Countries Arquimea Ingeniera invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Daniel González Gutiérrez
|
|||
Diego Fernandez
|
|||
Ferran Tejada Valero
|
|||
|
Idoia Picossi
|
|||
|
Jesús Delgado Alonso
|
|||
| See all 7 contacts → | |||
Investment Focus
Industry
- Medical 1 (100%)
- Pharmaceutical 1 (100%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Daniel González Gutiérrez
Space Programs Director
|
Space Programs Director | Total investments: 0 | Find email | |
|
Diego Fernandez
Founder & President
|
Founder & President | Total investments: 0 | Find email | |
|
Ferran Tejada Valero
General Manager
|
General Manager | Total investments: 0 | Find email | |
|
Idoia Picossi
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email | |
|
Jesús Delgado Alonso
CEO, Arquimea USA
|
CEO, Arquimea USA | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Vaxdyn
|
Vaxdyn develops vaccines using novel technology. They offers pathogen vaccines for preventing antibiotics-resistant infections. Their customers' inquiries are addressed through phone, email, and online applications. | $355.5K / Seed / Mar 08, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Arquimea Ingeniera invest in?
Arquimea Ingeniera invests primarily in Medical and Pharmaceutical startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Arquimea Ingeniera?
Public channels for Arquimea Ingeniera include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Arquimea Ingeniera?
The team at Arquimea Ingeniera includes Daniel González Gutiérrez (Space Programs Director), Diego Fernandez (Founder & President) and Ferran Tejada Valero (General Manager), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
